Maria Z Kounnas

Reelin Therapeutics, Inc.

$752,270

Attributed

$1,456,793

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $400K · FY2020–25

$500K$375K$250K$125K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$1,456,793 · 4

By mechanism

R43$798,548 · 2

R41$658,245 · 2

Top collaborators

Most similar at Reelin Therapeutics, Inc.

Same institution · by research overlap

Laurent Calvier$252,254

Others in their field

Other Emerging Leaders on “Cells”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Evan Z Macosko · Broad Institute, Inc.$33,096,828
James Dale Berry · Brigham And Women'S Hospital$30,122,905
Hanjoon Ryu$28,519,898
Eric C Palm · Florida State University$26,502,247

Research focus

CellsPathologySiteAlzheimer&AposBindingMouse ModelLeadMonoclonal AntibodiesInfiltrationHuman ModelIntercellular Adhesion Molecule 1Leukocyte Adhesion MoleculesInflammationExtravasationDegenerative DisorderEndothelial CellsAntibodiesDisease ProgressionApolipoprotein E Receptor 2ApolipoproteinsChronicE-SelectinExtracellular Matrix ProteinsInflammatory

Grant awards (5)

Identification of next generation gamma-secretase modulators for Alzheimer's disease$258,213

R41 · FY2025 · AG · contact PI

Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function$238,549

R43 · FY2024 · AG · contact PI

Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function$259,999

R43 · FY2023 · AG · contact PI

A novel role for Reelin therapeutics in rheumatoid arthritis$300,000

R43 · FY2022 · AR · contact PI

A novel role for Reelin therapeutics in inflammatory bowel disease$400,032

R41 · FY2020 · DK · contact PI